The Dermatology Digest

JANUARY 4, 2024

To find out more, researchers culled the literature to better define the dermatological burden of e-cigarettes and vaping. Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Vaping and Allergic Contact Dermatitis: What’s the link?

Dermatitis 69

Dermatitis Dermatology Medical Education 69

The Dermatology Digest

APRIL 9, 2024

Patient images are missing in studies of atopic dermatitis (AD), new research shows. ” The study is published in the Journal of Dermatological Treatment. “Images are also important for understanding that atopic dermatitis looks very different in different types of skin. This means that as little as 0.3

Eczema 74

Eczema Dermatitis Education Hospital 74

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. appeared first on The Dermatology Digest.

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. Zoryve foam; 48.3% of the total study population).

Dermatitis 72

Dermatitis Dermatology Office Safety 72

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. in seborrheic dermatitis.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

MARCH 21, 2024

March is National Sleep Awareness Month, and nighttime itching is known to keep families affected by atopic dermatitis (AD) up at night. Food and Drug Administration for VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older.

Dermatitis 68

Dermatitis Dermatology Medical Treatments 68

The Dermatology Digest

AUGUST 21, 2024

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds. The study, which appears in the Journal of Investigative Dermatology , comprises an analysis of 2,161,900 Korean children followed from 2009 to 2020.

Dermatitis 69

Dermatitis Diet Dermatology Medical 69

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

FEBRUARY 9, 2024

Early skin microbiome and metabolome signatures can predict atopic dermatitis in infants aged 6 to 18 months old, according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. The rates of atopic dermatitis were 30.8% in 6-month-old children and 20.8% at 18 months of age.

Dermatitis 74

Dermatitis Moisturization Training Dermatology 74

Dermatology Times

NOVEMBER 20, 2023

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Office 74

Office Dermatitis Medical Dermatology 74

US Dermatologt Partners

OCTOBER 7, 2024

Dermatitis is an umbrella term that refers to a group of skin conditions that cause skin irritation, sensitivity, redness, and similar symptoms. As the name implies, eyelid dermatitis or eyelid eczema, is a form of dermatitis that impacts the upper or lower eyelid. What is Eyelid Dermatitis?

Eczema 41

Eczema Dermatitis Irritation Management 41

The Dermatology Digest

JUNE 5, 2024

In the cross-sectional study, researchers analyzed data from more than 215,000 people aged 30 to 70 from the UK Biobank, which includef urine samples and electronic medical records. The post High-salt Diets Linked to Eczema appeared first on The Dermatology Digest.

Eczema 74

Eczema Diet Dermatitis Dermatology 74

The Dermatology Digest

JANUARY 31, 2024

Patients with vitiligo incur significantly higher healthcare costs than people without this skin condition, finds a new study in the Journal of Investigative Dermatology. ” –Khaled Ezzedine, MD, PhD, of the Department of Dermatology at AP-HP at Henri Mondor University Hospital in Créteil, France, in a news release. .

Hospital 69

Hospital Dermatitis Dermatology Medical 69

The Dermatology Digest

MARCH 11, 2024

Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, shares results from a late-breaker that she presented at the annual meeting of the American Academy of Dermatology in San Diego, CA.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

SEPTEMBER 14, 2023

Daniel Butler discusses strategies for diagnosing atypical dermatitis and overcoming medication access issues, including the use of alternative metrics to measure disease severity, practicing physician patience, and learning to navigate the payer system. We are so reliant on our physical exam skills [and] appropriately so. “And

Dermatitis 48

Dermatitis Treatments Medical Office 48

First Derm

SEPTEMBER 22, 2023

Online Dermatologist Keratosis Pilaris Medically reviewed by The Dermatologists and written by Dr. Alexander Börve Keratosis Pilaris (01) arm [ICD-10 L11.0] Associated with atopic dermatitis , asthma, and allergies. Try our FREE dermatology search engine and get peace of mind within a second What can I do? ICD-9: 701.1

Moisturization 98

Moisturization Pores Retinol Dermatology 98

First Derm

APRIL 5, 2024

Ensuring adherence to therapies in dermatology is paramount for enhancing treatment efficacy and promoting patient well-being. Prevalence of Poor Adherence Poor adherence is a significant issue in dermatology, leading to suboptimal treatment outcomes, disease exacerbation, and prolonged recovery periods.

Dermatology 45

Dermatology Treatments Education Medical 45

The Dermatology Digest

AUGUST 23, 2024

Janus kinase (JAK) inhibitors have had game-changing effects for patients with psoriasis, atopic dermatitis, vitiligo, and alopecia areata, but the use of these potent medications has been associated with JAK inhibitor-associated acne (JAKne). Miranti, MPAS, PA-C, a Physician Assistant with Riverchase Dermatology in Naples, FL.

Dermatology 74

Dermatology Dermatitis Medical Clinic 74

Dermatology Times

DECEMBER 10, 2024

Panelists discuss how managing atopic dermatitis presents complex clinical challenges, including treatment resistance, medication adherence, identifying triggers, and tailoring therapies to individual patient needs and disease severity.

Dermatitis 36

Dermatitis Clinic Therapy Management 36

Dermatology Times

DECEMBER 4, 2024

Gina Mangin, MPAS, PA-C, discusses how developing an effective atopic dermatitis treatment plan requires a personalized, multifaceted approach that combines proper skin care, trigger avoidance, topical medications, and potentially systemic therapies based on the severity of symptoms and individual patient needs.

Dermatitis 36

Dermatitis Treatments Therapy Medical 36

The Dermatology Digest

FEBRUARY 26, 2024

Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis. 3 Emollient enhancement, neonatal moisturizer, and barrier lipid replacement have all been discussed as epithelial barrier-protecting agents that may treat and possibly even prevent atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Moisturization 74

West Lake Dermatology

MARCH 25, 2024

Seborrheic Dermatitis (SD) is common skin condition known for its chronic and recurrent nature. Understanding seborrheic dermatitis is the first step towards managing it effectively. What Is Seborrheic Dermatitis? Who’s At Risk For Developing Seborrheic Dermatitis? SD can affect individuals of all ages and races.

Dermatitis 36

Dermatitis Treatments Eczema Management 36

US Dermatologt Partners

AUGUST 23, 2023

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. Dermatology Partners affiliate office Medical Dermatology Specialists in Phoenix, Arizona , “Like other chronic skin conditions, eczema is best managed with the help of a dermatologist.

Eczema 36

Eczema Dermatitis Management Skin Health 36

First Derm

APRIL 19, 2023

Online Dermatologist Cercarial Dermatitis (Swimmer’s itch) Medically reviewed by The Dermatologists and written by Dr. Alexander Börve Swimmer’s itch pictures initial stage U07.1 That is why it is given the name “cercarial” dermatitis. Receive expert dermatological advice from the comfort of your own home.

Dermatitis 40

Dermatitis Medical Document Management 40

The Dermatology Digest

APRIL 24, 2024

Among children with chronic skin disorders, predominantly acne, atopic dermatitis, alopecia areata, and vitiligo, 27% had minimal or no stigma, and 43.8% Paller, MS, MD, Chair of the Department of Dermatology and the Director of Skin Biology and Diseases Resource-Based Center and the Walter J. The study appears in JAMA Dermatology.

Dermatitis 69

Dermatitis Dermatology Tools Medical 69

The Dermatology Digest

JULY 6, 2024

In this new series, the Dermatology Digest asks top physicians about their over-the-counter (OTC) picks for various skin concerns. TDD: There’s lots of talk about steroid stewardship especially with the growing availability of non-steroid topical treatments for atopic dermatitis and psoriasis.

Eczema 74

Eczema Dermatitis Skin Types Dermatology 74

The Dermatology Digest

FEBRUARY 6, 2024

“ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date,” says ASA Chairman Howard P. The American Skin Association (ASA) announced its 2024 grant opportunities for dermatologists treating skin cancer and other diseases.

Dermatology 36

Dermatology Dermatitis Medical Education 36

Dermatology Times

AUGUST 20, 2024

A key opinion leader in the field of dermatology examines treatment strategies and medication sequencing for atopic and hand dermatitis in a 20-year-old female patient, focusing on clinical considerations and optimal management approaches.

Dermatitis 36

Dermatitis Management Clinic Medical 36

Dermatology Times

JULY 2, 2024

A medical expert in dermatology examines comprehensive treatment approaches for atopic dermatitis in a 12-year-old African American female patient, focusing on the assessment of topical and non-steroidal therapeutic options.

Dermatitis 36

Dermatitis Treatments Medical Dermatology 36

First Derm

JUNE 23, 2024

1] Three main categories of eczema are atopic eczema, contact dermatitis and stasis dermatitis. Despite the potential side effects, appropriate use of topical steroids under medical advice is beneficial for controlling eczema. [4] The American Contact Dermatitis Society recognizes it as an allergen.

Eczema 59

Eczema Ingredients Dermatitis Irritation 59

The Dermatology Digest

MARCH 9, 2024

Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, explains how he is using biosimilars in his practice during a talk at the American Academy of Dermatology’s annual meeting in San Diego. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Those with atopic dermatitis have lower resistance to the herpes infection. What is Eczema Herpeticum?

Eczema 52

Eczema Dermatitis Clinic Medical 52

Texas Dermatology

JUNE 8, 2023

For too long, medical research has focused primarily on the health needs of white individuals, neglecting the unique needs of people of color. Read more in our blog about the value of diversity in dermatology and the relevance of skin tone. As well as, have access to study medications, and receive compensation for time and travel.

Dermatology 36

Dermatology Skin Anatomy Dermatitis Eczema 36

The Dermatology Digest

JANUARY 20, 2024

In addition, due to its unique function on peripheral sensory neurons, EVO756 could provide fast relief of itch associated with inflammatory diseases, such as atopic dermatitis. The post Eye on Itch: Evommune Initiaties Phase I Study of EVO756 in CSU appeared first on The Dermatology Digest.

Safety 74

Safety Office Dermatitis Clinic 74

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures. Watch Now SOCS Turns 20!

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

The Dermatology Digest

AUGUST 13, 2024

Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common in people with Down syndrome including alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Clinic 74

Clinic Safety Dermatitis Medical 74

The Dermatology Digest

MAY 9, 2024

A microneedle patch that delivers immune-regulating molecules may teach T cells not to attack hair follicles, helping regrow hair in alopecia areata, according to research in mice from MIT, Brigham and Women’s Hospital, and Harvard Medical School. This innovative approach marks a paradigm shift. The study is published in Advanced Materials.

Microneedling 74

Microneedling Hospital Medical Dermatitis 74